Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.
Antimicrobials have transformed our ability to treat many infectious diseases that were killers only a few decades ago. The increasing use of antimicrobials in humans, animals, and agriculture has resulted in many pathogens developing resistance to these powerful drugs. All major groups of pathogens—viruses, fungi, parasites, and bacteria—can become resistant to antimicrobials.
Many diseases are increasingly difficult to treat because of the emergence of drug-resistant organisms, including HIV and other viruses; bacteria such as staphylococci, enterococci, and Escherichia coli; respiratory infections such as tuberculosis and influenza; foodborne pathogens such as Salmonella and Campylobacter; sexually transmitted organisms such as Neisseria gonorrhoeae; fungal infections such as Candida; and parasites such as the malaria-causing Plasmodium falciparum.
NIAID manages a research portfolio of grants specifically aimed at the problem of antimicrobial resistance and hospital-acquired infections.
The Antimicrobial Resistance Program supports research to
The Medical Bacteriology Program supports research to
back to top
Last Updated December 21, 2011